Innovative Medicines Canada engaged IQVIA in 2016 to create an annual Private Drug Plan Drug Cost Forecast which included a baseline analysis that projected forward using actual historical private drug […]
From the discovery of insulin to advances in stem cell […]
Currently, the proportion of uninsured Canadians in Canada […]
There has been an ongoing public debate as to why many Canadians are not taking their medications as prescribed. Often, it is argued that non-adherence can be attributed to cost. […]
Our members play an important role […]
Innovative Medicines Canada has been designated a Canadian Compassionate Company by the Canadian Hospice Palliative Care Association […]
For more than a century, Canada has been at the forefront of medical innovation. From the discovery of insulin to advances in stem cell research, Canadians have made significant scientific […]
We are stronger when we work with our partners.
Canada’s health ministers are currently undergoing a vigorous policy debate on how best to sustain our health-care system…
More than 24 million working Canadians and their families rely on timely and high quality access to medicines through employer-sponsored private drug plans. These plans help keep Canada’s working population […]
